What is the biologically effective dose (BED) for a total dose of 20 Gy delivered in 5 fractions?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 28, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

BED Calculation for 20 Gy in 5 Fractions

The biologically effective dose (BED) for 20 Gy delivered in 5 fractions is 28 Gy (assuming α/β = 10 Gy) or 36 Gy (assuming α/β = 3 Gy), depending on the tissue type being evaluated.

Calculation Method

The linear-quadratic (L-Q) model formula for calculating BED is: BED = D [1 + d/(α/β)] 1

Where:

  • D = total dose (20 Gy)
  • d = dose per fraction (20 Gy ÷ 5 fractions = 4 Gy)
  • α/β = tissue-specific ratio

Tissue-Specific BED Values

For Tumor Tissue (α/β = 10 Gy):

  • BED = 20 [1 + 4/10]
  • BED = 20 [1 + 0.4]
  • BED = 28 Gy₁₀

This is the standard assumption for most tumors and acute-reacting tissues 1.

For Late-Reacting Normal Tissue (α/β = 3 Gy):

  • BED = 20 [1 + 4/3]
  • BED = 20 [1 + 1.33]
  • BED = 36 Gy₃

This applies to late-responding tissues like spinal cord, brain, and other organs at risk.

Clinical Context

The 20 Gy in 5 fractions regimen is specifically mentioned in guidelines for:

  • Neuropathic pain from bone metastases, where this dose schedule (BED₁₀ = 28 Gy) is more effective than single 8 Gy fractions for pain control 2

  • Prophylactic cranial irradiation in extensive-stage small cell lung cancer, where 20 Gy in 5 fractions may be considered 3

  • Palliative radiotherapy for soft tissue sarcomas, where this is one of several acceptable palliative fractionation schemes 4

Important Caveats

The α/β ratio of 10 Gy is commonly used across various tumors as a standardized empirical rule 1, though actual values may vary by tumor type. The L-Q model becomes less accurate for doses exceeding 13 Gy per fraction 1, but remains valid for the 4 Gy per fraction used in this regimen.

When comparing treatment regimens, always calculate BED for both tumor (α/β = 10) and late-responding tissues (α/β = 2-3) to assess the therapeutic ratio 5.

References

Guideline

small cell lung cancer.

Journal of the National Comprehensive Cancer Network : JNCCN, 2011

Guideline

uk guidelines for the management of soft tissue sarcomas.

British Journal of Cancer, 2025

Research

Radiation related prognostic factors in radiation oncology.

European journal of gynaecological oncology, 2000

Related Questions

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.